Welcome!
Oriel Therapeutics is a specialty pharmaceutical company developing and commercializing products to improve respiratory care.  Combining an experienced product development team and a growing portfolio of innovative drug delivery technologies, Oriel is focused on delivering compelling patient options for the treatment of asthma and COPD. 



News

Oriel Therapeutics Appoints Richard Fuller as Chief Executive Officer
September 23, 2008 Read Full Article

Oriel Therapeutics, Inc. - receives 4th US Patent
For Immediate Release Read Full Article